Insider Trading May 4, 2026 06:18 PM

Popular, Inc. Executive Sells Over $920,000 in Common Stock

Executive Vice President Maria Cristina Gonzalez-Noguera liquidates 6,200 shares amid recent price strength and positive analyst revisions.

By Derek Hwang BPOP
Popular, Inc. Executive Sells Over $920,000 in Common Stock
BPOP

Maria Cristina Gonzalez-Noguera, an Executive Vice President at Popular, Inc. (NASDAQ: BPOP), has executed a sale of her company's common stock. According to regulatory filings made public on May 4, 2026, the transaction involved the disposal of 6,200 shares on May 1, 2026. The total value realized from this sale was approximately $920,786.

Key Points

  • Executive Maria Cristina Gonzalez-Noguera sold 6,200 shares of BPOP for approximately $920,786.
  • Popular, Inc. reported a strong EPS of $3.78, beating forecasts by 14.2%, despite a slight revenue miss.
  • Major analysts from Truist Securities and UBS have raised their price targets for the stock.

In a recent regulatory filing disclosed on May 4, 2026, Popular, Inc. (NASDAQ: BPOP) reported that Executive Vice President Maria Cristina Gonzalez-Noguera sold 6,200 shares of the company's common stock. The sale took place on May 1, 2026, and resulted in proceeds totaling roughly $920,786.

The transaction was executed at a weighted average price of $148.514 per share. Detailed records show that the individual prices for these transactions fluctuated within a range between $148.45 and $148.825 per share. Following this divestment, Ms. Gonzalez-Noguera maintains a direct ownership stake in Popular, Inc. consisting of 11,255.263 shares. This remaining balance includes 97.799 shares that were originally obtained through the reinvestment of corporate dividends.


This insider activity occurs while BPOP shares are trading near a 52-week high of $152.95, following a year in which the stock has climbed by 52%. This period of price appreciation coincides with a mixed financial report for the company's first quarter of 2026. While Popular, Inc. reported earnings per share (EPS) of $3.78-which surpassed market expectations by 14.2%-the company's revenue reached $835.81 million, missing projections by 1.63%.

Despite the slight revenue miss, several financial institutions have maintained an optimistic outlook on the firm. Truist Securities recently adjusted its price target for Popular upward to $172 from a previous $164, while retaining a Buy rating. Their analysis pointed toward improvements in operating leverage resulting from lower expenses and better management of deposit costs. Similarly, UBS raised its price target from $160 to $170, reaffirming the company's status as a Top Pick due to a robust start to the year.

Key Market Insights

  • Executive Liquidity: The sale by a high-ranking executive provides a data point on internal valuation perceptions during a period of significant stock price growth.
  • Financial Performance Divergence: There is a notable divergence between the company's strong EPS performance and its slight revenue shortfall, which impacts how the financial sector evaluates growth versus profitability.
  • Analyst Optimism: Upward revisions in price targets from major firms like Truist Securities and UBS suggest a positive outlook on the company's cost structures and operational efficiency.

Risks and Uncertainties

  • Revenue Performance: The 1.63% miss in revenue expectations highlights potential uncertainty regarding top-line growth trajectories within the banking sector.
  • Anticipated Capital Shifts: Market participants are looking toward upcoming second-quarter results, with expectations surrounding potential capital optimization plans that could influence future stock movement.

Risks

  • A recent revenue shortfall of 1.63% compared to expectations.
  • Uncertainty regarding potential capital optimization plans expected before Q2 results.

More from Insider Trading

Marcus & Millichap Director Executes Substantial Common Stock Purchase May 4, 2026 Patterson-UTI CEO Executes Multi-Million Dollar Stock Sale Amidst Year-to-Date Surge May 4, 2026 Snowflake Director Michael Speiser Executes $7.18 Million in Stock Sales May 4, 2026 Edwards Lifesciences Executive Executes Stock Transactions Amid Recent Financial Growth May 4, 2026 Entrada Therapeutics President and COO Executes Stock Sale via Rule 10b5-1 Plan May 4, 2026